Clinical Trial Update: Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer. [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating CHFR methylation status in patients with metastatic esophageal, gastroesophageal, and gastric cancers; study completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Metastatic Esophageal Cancer, Gastroesophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-03-15